Advertisement

Topics

Rare Disease Report® Forms Strategic Alliance Partnership with 31 Organizations

09:30 EDT 22 Jun 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Rare Disease Report®, the digital component of Rare Disease Communications®, is excited to welcome 31 organizations as part of the Strategic Alliance Partnership Program. Through this program, these leading medical inst...

Other Sources for this Article

Rare Disease Report® Media:
Theresa Burek
tburek@mjhassoc.com
or
Surabhi Verma
sverma@mjhassoc.com

NEXT ARTICLE

More From BioPortfolio on "Rare Disease Report® Forms Strategic Alliance Partnership with 31 Organizations"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Alliances, mergers acquisitions and partnerships
BioPortfolio's alliances, mergers acquisitions and partnerships channel provides the latest news and corporate information on the global bio-pharmaceutical industry.